Skip to content

13F-HR filed by Knoll Capital Management, LLC

Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-15, with 11 holding rows worth $146,208,000.

Accession
0001144204-13-046088
Filed
2013-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 11 entries on the cover page, a total value of $146,208,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $146,208,000 with VALUE read as thousands by filing date, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MEDIVATION INC58501N101COM2,504,101$123,202,000thousands by filing date
Ampio Pharmaceuticals03209T109COM1,308,455$7,550,000thousands by filing date
Alcobra LtdM2239P109SHS587,000$4,021,000thousands by filing date
SEQUENOM INC COM NEW817337405COM928,100$3,907,000thousands by filing date
GENWORTH FINL INC37247D106COM SHS320,000$3,651,000thousands by filing date
Vivus Inc.928551900Call5,000$1,430,000thousands by filing datecall
NEWLINK GENETICS CORP651511107COM47,437$935,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK100,000$747,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM55,000$450,000thousands by filing date
CELGENE CORP151020104COM27,925$204,000thousands by filing date
ECHO THERAPEUTICS INC27876L206COM NEW444,445$111,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-13-046088this filing2013-08-15acceptance time not in the bulk data set